Pomerantz LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX ) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-00508, is on behalf of a class consisting of all persons or …